LINC 2022: P-MAX Study with Dr Lichtenberg: ASPIREX®S Endovascular System

Подробнее о видео

Watch on Radcliffe Vascular:

Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, DE) joins us at LINC 2022 to outline the findings of the P-MAX Study, a post-market clinical follow-up to evaluate the safety and effectiveness of the ASPIREX®S Endovascular System in patients with deep vein thrombosis (DVT).

Discussion Points:
1. ASPIREX®S Endovascular System
2. Background of This Study
3. Study Design and Patient Population
4. Key Results
5. Recommended Use
6. Further Study Needed

Recorded on-site at LINC, Leipzig, 2022.

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.